Boston Scientific wins CE mark for 25-mm drug-eluting Lotus Transcatheter Aortic Valve

Boston Scientific's ($BSX) Ranger drug-coated balloon catheter was recently awarded a CE mark for its 25-mm Lotus Transcatheter Aortic Valve Implantation System, giving the company a new presence in the endovascular market complementing its 23-mm and 27-mm versions. The product, used to treat peripheral artery disease, will optimize drug delivery while using Sterling balloon technology and a paclitaxel coating to treat diseased vascular tissue without leaving a permanent implant. Currently, the product is being launched in Europe. Story

Suggested Articles

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.